Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Faroux

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Clinical Colorectal Cancer|August 2, 2011
Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR studyJaafar Bennouna, Christophe Borg, Jean-Pierre Delord, et al.
Canadian Journal of Gastroenterology & Hepatology|December 19, 2022
The Characteristics of Diverticular Disease in Caribbean Population: A Control Group StudyMoana Gelu-Simeon, Matthieu Schnee, Marie-Josée Lafrance, et al.
British Journal of Clinical Pharmacology|April 11, 2012
Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecanMarie-Christine Etienne-Grimaldi, Jaafar Bennouna, Jean-Louis Formento, et al.
BMC Cancer|November 11, 2008
Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association studySébastien Küry, Bruno Buecher, Sébastien Robiou-du-Pont, et al.
Seminars in Oncology|April 12, 2017
A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensificationMichèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 3, 2015
Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trialCôme Lepage, Jean-Marc Phelip, Laurent Cany, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 14, 2015
FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802)Thomas Aparicio, Benjamin Linot, Karine Le Malicot, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumptionSébastien Küry, Bruno Buecher, Sébastien Robiou-du-Pont, et al.
JAMA Oncology|January 23, 2016
DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical TrialValérie Boige, Marc Vincent, Philippe Alexandre, et al.
Genetic Testing|October 13, 2007
The thorough screening of the MUTYH gene in a large French cohort of sporadic colorectal cancersSébastien Küry, Bruno Buecher, Sébastien Robiou-du-Pont, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Clinical Colorectal Cancer|August 2, 2011
Bevacizumab combined with chemotherapy in the second-line treatment of metastatic colorectal cancer: results from the phase II BEVACOLOR studyJaafar Bennouna, Christophe Borg, Jean-Pierre Delord, et al.
Canadian Journal of Gastroenterology & Hepatology|December 19, 2022
The Characteristics of Diverticular Disease in Caribbean Population: A Control Group StudyMoana Gelu-Simeon, Matthieu Schnee, Marie-Josée Lafrance, et al.
British Journal of Clinical Pharmacology|April 11, 2012
Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecanMarie-Christine Etienne-Grimaldi, Jaafar Bennouna, Jean-Louis Formento, et al.
BMC Cancer|November 11, 2008
Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association studySébastien Küry, Bruno Buecher, Sébastien Robiou-du-Pont, et al.
Seminars in Oncology|April 12, 2017
A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensificationMichèle Boisdron-Celle, Jean Philippe Metges, Olivier Capitain, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 3, 2015
Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: The FFCD PRODIGE 13 randomised phase III trialCôme Lepage, Jean-Marc Phelip, Laurent Cany, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 14, 2015
FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802)Thomas Aparicio, Benjamin Linot, Karine Le Malicot, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2007
Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumptionSébastien Küry, Bruno Buecher, Sébastien Robiou-du-Pont, et al.
JAMA Oncology|January 23, 2016
DPYD Genotyping to Predict Adverse Events Following Treatment With Fluorouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer: A Secondary Analysis of the PETACC-8 Randomized Clinical TrialValérie Boige, Marc Vincent, Philippe Alexandre, et al.
Genetic Testing|October 13, 2007
The thorough screening of the MUTYH gene in a large French cohort of sporadic colorectal cancersSébastien Küry, Bruno Buecher, Sébastien Robiou-du-Pont, et al.
Pageof 5